Stable Istotope Labelled Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

Reference: PX-TA1269-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Crenezumab Biosimilar - Anti-APP Abeta42 and Abeta40 mAb - Research Grade
SourceCAS 1095207-05-8
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsMABT5102A,RG7412
ReferencePX-TA1269-SIL
Related ProductsPX-P1059
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-APP Abeta42 and Abeta40[Homo sapiens] (Crenezumab) Monoclonal Antibody

Crenezumab has been investigated for the treatment of Alzheimer’s Disease.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.